Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zhi-Qian Liu is active.

Publication


Featured researches published by Zhi-Qian Liu.


Acta Crystallographica Section E: Crystallographic Communications | 2006

1‐Acetyl‐3,3‐bis­[3‐(2‐methyl­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]‐1H‐indolin‐2(3H)‐one

Xiao-Chen Yan; Hai-Bo Wang; Zhi-Qian Liu

The molecular structure of (I) is shown in Fig. 1 and selected bond lengths and angles are given in Table 1. The indanone ring system is planar and the acetyl group at N5 is twisted by 11.8 (2) . The dihedral angle between the O1/N1/ N2/C8/C9 and C1–C6 planes is 9.3 (2) and that between the O4/N3/N4/C22/C23 and C25–C30 planes is 43.9 (1) . Intramolecular C—H N and C—H O hydrogen bonds are observed in the molecular structure. The crystal structure is stabilized by intermolecular C—H O and C—H N hydrogen bonds (Table 2).


Acta Crystallographica Section E-structure Reports Online | 2006

Methyl 2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-ylmethoxy]phenylacetate

Zhi-Qian Liu; Xiao-Chen Yan; Hai-Bo Wang

1,2,4-Oxadiazole derivatives are of great interest because of their biological properties. Some derivatives of 1,2,4oxadiazole have intrinsic analgesic (Terashita et al., 2002), anti-inflammatory (Nicolaides et al., 1998) and antipicornaviral (Romero, 2001) properties and show high efficacy as agonists [e.g. for muscarinic (Macor et al., 1996), adrenergic (Quagliato & Andrae, 2002) and 5-hydroxytryptamine (Gur et al., 2001)] and antagonists [e.g. for angiotensin (Naka & Kubo, 1999) and adhesion (Juraszyk et al., 1997)] for different receptors. We report here the crystal structure of the title compound, (I).


Acta Crystallographica Section E: Crystallographic Communications | 2006

5-Chloro­methyl-3-(2,4-dichloro­phen­yl)-1,2,4-oxadiazole

Hai-Bo Wang; Zhi-Qian Liu; Xiao-Chen Yan


Acta Crystallographica Section E-structure Reports Online | 2006

1-Acetyl-3,3-bis­[3-(3-methoxy­phen­yl)-1,2,4-oxadiazol-5-ylmeth­yl]indolin-2-one

Xiao-Chen Yan; Zhi-Tao Xing; Zhi-Qian Liu; Hai-Bo Wang


Acta Crystallographica Section E-structure Reports Online | 2006

[3-(4-Chloro­phen­yl)-1,2,4-oxadiazol-5-yl]methanol

Xiao-Chen Yan; Hai-Bo Wang; Zhi-Qian Liu


Acta Crystallographica Section E: Crystallographic Communications | 2006

4-Methyl­benzamide oxime

Hai-Bo Wang; Xiao-Chen Yan; Zhi-Qian Liu


Acta Crystallographica Section E: Crystallographic Communications | 2006

1-{[3-(4-Bromo­phen­yl)-1,2,4-oxadiazol-5-yl]meth­yl}-4-[(2,6-dimethyl­phen­yl)amino­carbonyl­meth­yl]piperazine

Hai-Bo Wang; Zhi-Qian Liu; Xiao-Chen Yan


Acta Crystallographica Section E: Crystallographic Communications | 2006

3-Methoxy­benzamide oxime

Xiao-Chen Yan; Zhi-Qian Liu; Hai-Bo Wang


Acta Crystallographica Section E-structure Reports Online | 2006

5-Bromo-2-iodo­pyrimidine

Zhi-Tao Xing; Wei-Lin Ding; Hai-Bo Wang; Zhi-Qian Liu; Pin-Liang Wang


Acta Crystallographica Section E-structure Reports Online | 2006

2-{2-[3-(2-Chlorophenyl)-1,2,4-oxadiazol-5-yl]phenoxy}-N-(2,6-dimethylphenyl)acetamide

Wei-Lin Ding; Zhi-Tao Xing; Zhi-Qian Liu; Pin-Liang Wang; Hai-Bo Wang

Collaboration


Dive into the Zhi-Qian Liu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge